Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for intentionality understanding in boys with ADHD
IRCT20201103049254N1Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Primary endpoint: Neural correlate of understanding intentionality. Started Oct 2020; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20201103049254N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201103049254N1.